OBJECTIVES: To explore the relation between nephrologists' characteristics and their views of transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant of older patients. MATERIALS AND METHODS: A comprehensive international Web-based survey explored the relation between nephrologists' characteristics and their views of transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant of older patients. RESULTS: A total of 1448 nephrologists completed the survey. The majority of respondents agreed with transplant as the treatment of choice for end-stage renal disease (75%), preemptive transplant (71%), and transplant for patients > 60 years of age (59%). The likelihood of agreement was higher among transplant and academic nephrologists, and practice at hospitals with ≥ 50 transplants per year. Urban location and ≥ 10 years in practice were associated with higher likelihood of viewing transplant as treatment of choice and favoring preemptive transplant. CONCLUSIONS: Demographic and practice characteristics influence nephrologists' attitudes about transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant as an option for older patients. Detailed studies exploring the determinants of nephrologists' attitudes are likely to identify sources of variations in perceptions of patient suitability for transplant. Our findings underscore the need for continuing educational programs addressing evolving aspects of transplant particularly targeting nephrologists practicing within nonacademic centers and in rural areas.
OBJECTIVES: To explore the relation between nephrologists' characteristics and their views of transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant of older patients. MATERIALS AND METHODS: A comprehensive international Web-based survey explored the relation between nephrologists' characteristics and their views of transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant of older patients. RESULTS: A total of 1448 nephrologists completed the survey. The majority of respondents agreed with transplant as the treatment of choice for end-stage renal disease (75%), preemptive transplant (71%), and transplant for patients > 60 years of age (59%). The likelihood of agreement was higher among transplant and academic nephrologists, and practice at hospitals with ≥ 50 transplants per year. Urban location and ≥ 10 years in practice were associated with higher likelihood of viewing transplant as treatment of choice and favoring preemptive transplant. CONCLUSIONS: Demographic and practice characteristics influence nephrologists' attitudes about transplant as the treatment of choice for end-stage renal disease, preemptive transplant, and transplant as an option for older patients. Detailed studies exploring the determinants of nephrologists' attitudes are likely to identify sources of variations in perceptions of patient suitability for transplant. Our findings underscore the need for continuing educational programs addressing evolving aspects of transplant particularly targeting nephrologists practicing within nonacademic centers and in rural areas.
Authors: Shayna L Lunsford; Kit S Simpson; Kenneth D Chavin; Laura G Hildebrand; Lucia G Miles; Lilless M Shilling; Gilbert R Smalls; Prabhakar K Baliga Journal: Am J Kidney Dis Date: 2006-02 Impact factor: 8.860
Authors: Jesse D Schold; Bruce Kaplan; Neale R Chumbler; Richard J Howard; Titte R Srinivas; Linan Ma; Herwig-Ulf Meier-Kriesche Journal: J Am Soc Nephrol Date: 2005-08-31 Impact factor: 10.121
Authors: Denise Charron-Prochownik; Susan M Sereika; Donna Falsetti; Shiaw-Ling Wang; Dorothy Becker; Scott Jacober; Joan Mansfield; Neil H White Journal: Pediatr Diabetes Date: 2006-10 Impact factor: 4.866
Authors: Françoise G Pradel; Rahul Jain; C Daniel Mullins; Joseph A Vassalotti; Stephen T Bartlett Journal: Clin J Am Soc Nephrol Date: 2008-10-01 Impact factor: 8.237
Authors: Michael Abecassis; Stephen T Bartlett; Allan J Collins; Connie L Davis; Francis L Delmonico; John J Friedewald; Rebecca Hays; Andrew Howard; Edward Jones; Alan B Leichtman; Robert M Merion; Robert A Metzger; Francoise Pradel; Eugene J Schweitzer; Ruben L Velez; Robert S Gaston Journal: Clin J Am Soc Nephrol Date: 2008-02-06 Impact factor: 8.237
Authors: Pam Leece; Mohit Bhandari; Sheila Sprague; Marc F Swiontkowski; Emil H Schemitsch; Paul Tornetta; P J Devereaux; Gordon H Guyatt Journal: J Med Internet Res Date: 2004-09-24 Impact factor: 5.428
Authors: Jennifer Gander; Teri Browne; Laura Plantinga; Stephen O Pastan; Leighann Sauls; Jenna Krisher; Rachel E Patzer Journal: Am J Nephrol Date: 2015-08-06 Impact factor: 3.754
Authors: Meera N Harhay; Maya K Rao; Kenneth J Woodside; Kirsten L Johansen; Krista L Lentine; Stefan G Tullius; Ronald F Parsons; Tarek Alhamad; Joseph Berger; XingXing S Cheng; Jaqueline Lappin; Raymond Lynch; Sandesh Parajuli; Jane C Tan; Dorry L Segev; Bruce Kaplan; Jon Kobashigawa; Darshana M Dadhania; Mara A McAdams-DeMarco Journal: Nephrol Dial Transplant Date: 2020-07-01 Impact factor: 5.992
Authors: S Joseph Kim; John S Gill; Greg Knoll; Patricia Campbell; Marcelo Cantarovich; Edward Cole; Bryce Kiberd Journal: J Am Soc Nephrol Date: 2019-08-06 Impact factor: 10.121